Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed on April 2, 2025 ...

Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed ...

Net revenue for the three months ended March 31, 2025, was approximately $0.3 million, reflecting sales of the QUELIMMUNE ...